daunorubicin has been researched along with Endodermal Sinus Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, Y; He, D; He, Y; Hua, Y; Li, M; Li, X; Lin, T; Liu, D; Wang, Q; Wang, Z; Wei, G; Wen, S; Zhu, J | 1 |
1 other study(ies) available for daunorubicin and Endodermal Sinus Tumor
Article | Year |
---|---|
Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endodermal Sinus Tumor; Flow Cytometry; Genetic Vectors; Microbubbles; Rats; RNA, Small Interfering; Ultrasonics | 2011 |